Survivors share their stories to shape better cancer Follow-Up care
NCT ID NCT03515993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how gynecological cancer survivors feel and function after finishing their main treatment. About 1,100 people who are currently cancer-free will answer questionnaires about their quality of life, anxiety, sexual health, and more. The goal is to learn what matters most to survivors so doctors can improve follow-up care. No new treatments or drugs are being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliera Ordine Mauriziano di Torino
Torino, Italy
-
Centre Hospitalier Chretien (CHC) - CHC MontLegia
Liège, Belgium
-
Complejo Hospitalario de Navarra
Pamplona, Spain
-
East Kent Hospitals University NHS Foundation Trust - Queen Elizabeth The Queen Mother Hospita
Margate, Kent, CT9 4AN, United Kingdom
-
HELIOS Kliniken - Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke
Wuppertal, Germany
-
Hospital Universitario La Paz
Madrid, Spain
-
Hospital Universitario San Carlos
Madrid, Spain
-
Hospital Universitario de Salamanca
Salamanca, Spain
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Naples, Italy
-
King Hussein Cancer Center
Amman, 11941, Jordan
-
Medical University Of Gdansk
Gdansk, PL 80 211, Poland
-
Medical University of Graz
Graz, 8036, Austria
-
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital
Glasgow, United Kingdom
-
Northampton General Hospital NHS Trust
Cliftonville, Northampton, NN1 5BD, United Kingdom
-
Ospedale San Gerardo
Monza, Italy
-
Radboudumc - Radboud University Medical Center Nijmegen
Nijmegen, NL 6525, Netherlands
-
UMC-Academisch Ziekenhuis Utrecht
Utrecht, NL 3584 CX, Netherlands
-
Universitaetsklinikum Schleswig-Holstein - Campus Kiel
Kiel, Germany
-
Universitair Ziekenhuis Gent
Ghent, Belgium
-
ZNA Jan Palfijn
Merksem, Belgium
-
ZNA Middelheim
Antwerp, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- What raises endometrial cancer risk in black women? a study digs in
- Can a new PET tracer light up hidden cancers?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women